164 related articles for article (PubMed ID: 16876786)
1. Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action.
Parmeggiani A; Nissen P
FEBS Lett; 2006 Aug; 580(19):4576-81. PubMed ID: 16876786
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.
Parmeggiani A; Krab IM; Okamura S; Nielsen RC; Nyborg J; Nissen P
Biochemistry; 2006 Jun; 45(22):6846-57. PubMed ID: 16734421
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
4. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
5. Synergism between the GTPase activities of EF-Tu.GTP and EF-G.GTP on empty ribosomes. Elongation factors as stimulators of the ribosomal oscillation between two conformations.
Mesters JR; Potapov AP; de Graaf JM; Kraal B
J Mol Biol; 1994 Oct; 242(5):644-54. PubMed ID: 7932721
[TBL] [Abstract][Full Text] [Related]
6. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
7. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics MDL 62,879 and kirromycin bind to distinct and independent sites of elongation factor Tu (EF-Tu).
Landini P; Soffientini A; Monti F; Lociuro S; Marzorati E; Islam K
Biochemistry; 1996 Dec; 35(48):15288-94. PubMed ID: 8952479
[TBL] [Abstract][Full Text] [Related]
9. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
10. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
Navratil T; Spremulli LL
Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
[TBL] [Abstract][Full Text] [Related]
12. Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics.
Parmeggiani A; Krab IM; Watanabe T; Nielsen RC; Dahlberg C; Nyborg J; Nissen P
J Biol Chem; 2006 Feb; 281(5):2893-900. PubMed ID: 16257965
[TBL] [Abstract][Full Text] [Related]
13. Interaction of apicoplast-encoded elongation factor (EF) EF-Tu with nuclear-encoded EF-Ts mediates translation in the Plasmodiumfalciparum plastid.
Biswas S; Lim EE; Gupta A; Saqib U; Mir SS; Siddiqi MI; Ralph SA; Habib S
Int J Parasitol; 2011 Mar; 41(3-4):417-27. PubMed ID: 21163263
[TBL] [Abstract][Full Text] [Related]
14. New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu.
Anborgh PH; Parmeggiani A
EMBO J; 1991 Apr; 10(4):779-84. PubMed ID: 2009857
[TBL] [Abstract][Full Text] [Related]
15. Possible evolution of factors involved in protein biosynthesis.
Nyborg J
Acta Biochim Pol; 1998; 45(4):883-94. PubMed ID: 10397336
[TBL] [Abstract][Full Text] [Related]
16. The identification of the determinants of the cyclic, sequential binding of elongation factors tu and g to the ribosome.
Yu H; Chan YL; Wool IG
J Mol Biol; 2009 Feb; 386(3):802-13. PubMed ID: 19154738
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of active elongation factor Tu reveals major domain rearrangements.
Berchtold H; Reshetnikova L; Reiser CO; Schirmer NK; Sprinzl M; Hilgenfeld R
Nature; 1993 Sep; 365(6442):126-32. PubMed ID: 8371755
[TBL] [Abstract][Full Text] [Related]
18. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
[TBL] [Abstract][Full Text] [Related]
19. How can elongation factors EF-G and EF-Tu discriminate the functional state of the ribosome using the same binding site?
Sergiev PV; Bogdanov AA; Dontsova OA
FEBS Lett; 2005 Oct; 579(25):5439-42. PubMed ID: 16213500
[TBL] [Abstract][Full Text] [Related]
20. Binding of tetracyclines to elongation factor Tu, the Tet repressor, and the ribosome: a molecular dynamics simulation study.
Aleksandrov A; Simonson T
Biochemistry; 2008 Dec; 47(51):13594-603. PubMed ID: 19032078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
